Recombinant CD40 / TNFRSF5 / CD40L-Receptor Antibody [CD40/9814R]

In Stock
Catalog Number Formulation Size Price
958-RBM15-P0
Purified Ab with BSA and Azide at 200ug/ml
20ug
$259.00
958-RBM15-P1
Purified Ab with BSA and Azide at 200ug/ml
100ug
$559.00
958-RBM15-P1ABX
Purified Ab WITHOUT BSA or Azide at 1.0mg/ml
100ug
$559.00
Flat Rate Domestic: $95 | Orders outside the US - Contact Us for Order Information | Ships next business day

Applications & Dilutions

Applications Tested Dillution Protocol
Western Blot (WB)
2-4ug/ml

Summary

Receptor for TNFSF5/CD40LG (PubMed:31331973). Transduces TRAF6- and MAP3K8-mediated signals that activate ERK in macrophages and B cells, leading to induction of immunoglobulin secretion (By similarity).

Product Properties & Targets

Host
Rabbit
Applications
Species Reactivity
Isotype / Light Chain
IgG / Kappa
Cellular Localization
Cell membrane, Secreted
Gene Name
Positive Control
B-cells and in primary carcinomas
Immunogen
Recombinant human CD40 protein
Alternate Names
Tumor necrosis factor receptor superfamily member 5, Bp50|CDW40|TNFRSF5|p50

Database Links

Entrez Gene ID
958
SwissProt

Additional Information

Clone
CD40/9814R
Chromosome Location
20q13.12
Mol. Weight of Antigen
30.62kDa
Purification
Protein G

Functions

  • Receptor for TNFSF5/CD40LG (PubMed:31331973). Transduces TRAF6- and MAP3K8-mediated signals that activate ERK in macrophages and B cells, leading to induction of immunoglobulin secretion (By similarity).

Storage & Stability

Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

Limitations

This antibody is available for research use only and is not approved for use in diagnosis.

Supplied as

200ug/ml of Ab produced in a mammalian-based expression system. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.

Warranty

There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.
PARTNERSHIP OPPORTUNITIES

NeoBiotechnologies holds Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.

LETS TALK